Technetium-99m-sestamibi scintimammography for the detection of breast carcinoma: Comparison between planar and SPECT imaging

Journal of Nuclear Medicine

Volumn 39, Issue 5, 1998, Pages 849-856

  Tiling, Reinhold ^a   Tatsch, Klaus ^b   Sommer, Harald ^b   Meyer, Gabriele ^b   Pechmann, Martina ^b   Gebauer, Katrin ^b   Münzing, Wolfgang ^b   Linke, Rainer ^b   Khalkhali, Iraj ^b   Hahn, Klaus ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

Breast carcinoma; Breast imaging; Scintimammography; SPECT

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE; PREDICTION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX SCINTISCANNING; TISSUE DISTRIBUTION;

ALGORITHMS; BREAST DISEASES; BREAST NEOPLASMS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 18344401992     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. American Cancer Society. Cancer facts and figures. Atlanta, GA: American Cancer Society, 1992.
2. Ries LAG, Hankey BF, Miller BA, Hartman AM, Edwards BK. Cancer statistics review [Abstract). J Nutl Cancer Inst 1991;91:2780P.
3. Wingo PA, Tong T, Boldem S. Cancer statistics, 1995. CA Cancer J Clin 1995;45: 8-30.
4. Tabar L, Fagerberg CJ, Gad A, et al. Reduction of mortality from breast cancer after mass screening with mammography: randomized trial from the breast cancer screening working group of the Swedish National Board of Health and Welfare. Lancet 1985;1:829-832.
5. Jackson VP, Hendrick RE, Kerg SA, et al. Imaging of the radiographically dense breast. Radiology 1993;198:297-301.
6. Meyer JE, Sonnenfeld MR, Greenes RA, Stomper PC. Preoperative localization of clinically occult breast lesions: experience at a referral hospital. Radiology 1988;169: 627-628.
7. Sickles EA. Mammographic features of 300 consecutive nonpalpable breast cancers. Am J Roentgenol 1986;146:661-663.
8. Spivey GH, Perry BW, Clark VA, Coulson AH, Coulson WF. Predicting the risk of cancer at the time of breast biopsy: variation in the benign to malignant ratio. Am Surg 1982;48:326-332.
9. Adler DD, Wahl RL. New methods for imaging the breast: techniques, findings, and potential. Am J Roentgenol 1995;164:19-30.
10. 18F fluordeoxyglucose. J Clin Oncol 1996;14: 1848-1857.
11. Harms SE, Flamig DP, Evans WP, Harries SA, Bown S. MR imaging of the breast: current status and future potential. Am J Roentgenol 1994;163:1039-1047.
12. Weinreb JC, Newstead G. MR imaging of the breast. Radiology 1995;196:593-610.
13. 99mTc-MIBI: a comparative study with mammography and ultrasonography. Nucl Med Commun 1994;15:604-612.
14. Khalkhali I, Mena I, Diggles L. Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi. Eur J Nucl Med 1994;21:357-362.
15. 99mTc sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 1995;196:421-426.
16. Khalkhali I, Cutrone J, Mena I, et al. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up. J Nucl Med 1995;36:1784-1789.
17. Palmedo H, Schomburg A, Grünwald F, Mallmann P, Krebs D, Biersack HJ. Technetium-99m-MIBI scintimammography for suspicious breast lesions. J Nucl Med 1996;37:626-630.
18. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperriere J. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995;36:1758-1765.
19. 99mTc sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesions. J Nucl Med 1997;38:58-62.
20. 99mTc methoxy isobutal isonitrile (MIBI) in the evaluation of primary carcinoma of the breast: comparison of palpable and nonpalpable lesions with mammography [Abstract]. J Nucl Med 1994;35:22.
21. Diggles L, Khalkhali I. SPECT prone dependent-breast scintimammography [Abstract]. Ear J Nucl Med 1994;21:769P.
22. Luig H, Eschner W, Bähre M, Voth E, Nolte G. An iterative strategy for determination of the source distribution in single-photon emission tomography with a rotating gamma camera (SPECT). Nuklearmedizin 1988;27:140-146.
23. Luig H, Eschner W, Nolte G, Bähre M, Voth E. In: Schmidt HAE, Csernay L, eds. Multiplicative iterative SPECT reconstruction (MISR): an approach to exact absorption correction. New trends and possibilities in nuclear medicine. Stuttgart, New York: Schattauer; 1988:101-104.
24. Kopans DB. The positive predictive value of mammography. Am J Roentgenol 1992;158:521-526.
25. Kopans DB. Breast imaging. Philadelphia: J.B. Lippincott Co., 1989:320.
26. Mena FJ, Mena I, Diggles LE, Khalkhali I. Design and assessment of a scintigraphy-guided biplane localization technique for breast tumours: a phantom study. Nucl Med Commun 1996;17:717-723.
27. Khalkhali I, Mishkin FS, Diggles LE, Klein SR. Radionuclide-guided localization of nonpalpable breast lesions in patients with normal mammograms. J Nucl Med 1997;38:1019-1022.